Kwon Hye-Mee, Jeong Youngil, Kim Kyoung-Sun, Jung Kyeo-Woon, Moon Young-Jin, Hwang Gyu-Sam
Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Anesth Pain Med (Seoul). 2019 Oct 31;14(4):465-473. doi: 10.17085/apm.2019.14.4.465.
Diabetes mellitus (DM) increases risk of heart failure. It has been shown that diabetes leads to DM-cardiomyopathy, characterized by systolic and diastolic dysfunction. Pre-transplant diastolic dysfunction, has been associated with poor graft outcome and mortality. We assessed the hypothesis that end-stage liver disease (ESLD) patients with diabetes (DM-ESLD), have more advanced cardiac systolic and diastolic dysfunction, compared to ESLD patients without diabetes (Non DM-ESLD).
We retrospectively evaluated preoperative echocardiography of 1,319 consecutive liver transplant recipients (1,007 Non DM-ESLD vs. 312 DM-ESLD [23.7%]) January 2012-May 2016. Systolic and diastolic indices, such as left ventricular ejection fraction, transmital E/A ratio, tissue doppler s', e' velocity, and E/e' ratio (index of left ventricular end-diastolic pressure), were compared using 1:2 propensity-score matching.
DM-ESLD patients showed no differences in systolic indices of left ventricular ejection fraction and s' velocity, whereas diastolic indices of E/A ratio ≤ 1 (49.0% vs. 40.2% P = 0.014), e' velocity (median = 7.0 vs. 7.4 cm/s, P < 0.001) and E/e' ratio (10.9 ± 3.2 vs. 10.1 ± 3.0, P < 0.001), showed worse diastolic function compare with Non DM-ESLD patients, respectively.
DM-ESLD patients suffer higher degree of diastolic dysfunction compared with Non DM-ESLD patients. Based on this, careful preoperative screening for diastolic dysfunction in DM-ESLD patients is encouraged, because poor transplant outcomes have been noted in patients with preoperative diastolic dysfunction.
糖尿病(DM)会增加心力衰竭的风险。研究表明,糖尿病会导致糖尿病性心肌病,其特征为收缩和舒张功能障碍。移植前的舒张功能障碍与移植物预后不良和死亡率相关。我们评估了这样一个假设,即与无糖尿病的终末期肝病(ESLD)患者(非DM-ESLD)相比,患有糖尿病的终末期肝病(DM-ESLD)患者存在更严重的心脏收缩和舒张功能障碍。
我们回顾性评估了2012年1月至2016年5月期间1319例连续肝移植受者(1007例非DM-ESLD患者与312例DM-ESLD患者[23.7%])的术前超声心动图检查结果。使用1:2倾向评分匹配比较收缩和舒张指标,如左心室射血分数、经胸E/A比值、组织多普勒s'、e'速度以及E/e'比值(左心室舒张末期压力指标)。
DM-ESLD患者在左心室射血分数和s'速度的收缩指标上无差异,而E/A比值≤1(49.0%对40.2%,P = 0.014)、e'速度(中位数 = 7.0对7.4 cm/s,P < 0.001)和E/e'比值(10.9 ± 3.2对10.1 ± 3.0,P < 0.001)的舒张指标显示,与非DM-ESLD患者相比,其舒张功能更差。
与非DM-ESLD患者相比,DM-ESLD患者存在更高程度的舒张功能障碍。基于此,鼓励对DM-ESLD患者进行术前舒张功能障碍的仔细筛查,因为术前舒张功能障碍的患者已被观察到移植预后不良。